MAP3K4 is critical for the resistance to BRAF inhibitor in melanoma

被引：0
|
作者：
Hong, J. [1 ,2 ]
Lee, T. [3 ]
Wee, W. [3 ]
Chen, Y. [4 ]
机构：
[1] Natl Taiwan Univ, Coll Med, Grad Inst Med Genom & Prote, Taipei, Taiwan
[2] Natl Taiwan Univ, Coll Med, Dept Dermatol, Taipei, Taiwan
[3] Natl Taiwan Univ Hosp, Dept Dermatol, Taipei, Taiwan
[4] Natl Taiwan Univ, Grad Inst Med Genom & Prote, Taipei, Taiwan
来源：
JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2018年 / 138卷 / 05期
关键词：
D O I：
10.1016/j.jid.2018.03.1233
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
1218
引用
收藏
页码：S207 / S207
页数：1
相关论文
共 50 条
  • [21] LncRNA-MAP3K4 Regulates Vascular Inflammation Through a P38 MAPK Signaling Pathway and Cis-modulation of MAP3K4
    Zhou, HaoYang
    Simion, Viorel
    Pierce, Jacob
    Feinberg, Mark W.
    CIRCULATION, 2020, 142
  • [22] The MAP3K4 SNP rs1534020 is associated with obesity and blood pressure in prepubertal children
    Aguilera, Concepcion M.
    Olza, Josune
    Gil-Campos, Mercedes
    Leis, Rosaura
    Tojo, Rafael
    Canete, Ramon
    Gil, Angel
    ANNALS OF NUTRITION AND METABOLISM, 2015, 67 : 283 - 284
  • [23] Transgenic expression of Map3k4 rescues T-associated sex reversal (Tas) in mice
    Warr, Nick
    Siggers, Pam
    Carre, Gwenn-Ael
    Bogani, Debora
    Brixey, Rachel
    Akiyoshi, Mika
    Tachibana, Makoto
    Teboul, Lydia
    Wells, Sara
    Sanderson, Jeremy
    Greenfield, Andy
    HUMAN MOLECULAR GENETICS, 2014, 23 (11) : 3035 - 3044
  • [24] Oncogenic PI3K/AKT promotes the step-wise evolution of combination BRAF/MEK inhibitor resistance in melanoma
    Mal Irvine
    Ashleigh Stewart
    Bernadette Pedersen
    Suzanah Boyd
    Richard Kefford
    Helen Rizos
    Oncogenesis, 7
  • [25] Oncogenic PI3K/AKT promotes the step-wise evolution of combination BRAF/MEK inhibitor resistance in melanoma
    Irvine, Mal
    Stewart, Ashleigh
    Pedersen, Bernadette
    Boyd, Suzanah
    Kefford, Richard
    Rizos, Helen
    ONCOGENESIS, 2018, 7
  • [26] Overcoming the resistance to BRAF inhibitor by the double BRAF and MEK inhibitions in advanced melanoma: a case report
    Kattan, Joseph
    Kattan, Clarisse
    Farhat, Fadi
    Assi, Tarek
    ANTI-CANCER DRUGS, 2019, 30 (10) : 1052 - 1054
  • [27] Upregulation of MicroRNA-1246 Is Associated with BRAF Inhibitor Resistance in Melanoma Cells with Mutant BRAF
    Kim, Jae-Hyeon
    Ahn, Jun-Ho
    Lee, Michael
    CANCER RESEARCH AND TREATMENT, 2017, 49 (04): : 947 - 959
  • [28] Acquired and intrinsic BRAF inhibitor resistance in BRAF V600E mutant melanoma
    Fedorenko, Inna V.
    Paraiso, Kim H. T.
    Smalley, Keiran S. M.
    BIOCHEMICAL PHARMACOLOGY, 2011, 82 (03) : 201 - 209
  • [29] Effects of AKT inhibitor therapy in response and resistance to BRAF inhibition in melanoma
    Lassen, Amanda
    Atefi, Mohammad
    Robert, Lidia
    Wong, Deborah J. L.
    Cerniglia, Michael
    Comin-Anduix, Begonya
    Ribas, Antoni
    MOLECULAR CANCER, 2014, 13
  • [30] Acquired Resistance and Clonal Evolution in Melanoma during BRAF Inhibitor Therapy
    Shi, Hubing
    Hugo, Willy
    Kong, Xiangju
    Hong, Aayoung
    Koya, Richard C.
    Moriceau, Gatien
    Chodon, Thinle
    Guo, Rongqing
    Johnson, Douglas B.
    Dahlman, Kimberly B.
    Kelley, Mark C.
    Kefford, Richard F.
    Chmielowski, Bartosz
    Glaspy, John A.
    Sosman, Jeffrey A.
    van Baren, Nicolas
    Long, Georgina V.
    Ribas, Antoni
    Lo, Roger S.
    CANCER DISCOVERY, 2014, 4 (01) : 80 - 93
12345